Understanding Your Bowel Health: The Role of the qFIT Test
Bowel health is a topic that many people find difficult to discuss, yet it is a crucial aspect of our overall wellbeing. In the United Kingdom, bowel cancer is one of the most common types of cancer, making awareness and proactive monitoring essential. One of the most effective tools in this proactive approach is the Quantitative Faecal Immunochemical Test, commonly known as qFIT. This simple, non-invasive test has revolutionised how we screen for potential bowel issues, offering a reliable way to detect early warning signs before symptoms even appear.
What is a qFIT Test?
The Quantitative Faecal Immunochemical Test (qFIT) is a highly sensitive screening tool designed to detect microscopic traces of blood in your stool (poo). Unlike older tests, qFIT specifically targets human haemoglobin, making it much more accurate and less likely to be affected by your diet or medications. The presence of hidden blood can be an early indicator of various bowel conditions, including polyps (small growths on the inner lining of the colon or rectum) and bowel cancer. [1]
The test is straightforward and can be completed in the privacy of your own home. It involves collecting a small sample of your stool using a specially designed kit, which is then sent to a laboratory for analysis. The laboratory measures the exact amount of blood present, providing a quantitative result that helps healthcare professionals determine the next best steps for your care. [2]
Why is qFIT Important?
The primary value of the qFIT test lies in its ability to detect potential issues early. Bowel cancer often develops slowly, and in its early stages, it may not cause any noticeable symptoms. By the time symptoms such as a persistent change in bowel habits, abdominal pain, or visible blood in the stool become apparent, the condition may be more advanced. [3]
According to Cancer Research UK, when bowel cancer is diagnosed at its earliest stage, more than 9 in 10 people will survive their disease for five years or more. [4] The qFIT test plays a vital role in this early detection strategy, helping to identify individuals who may need further investigation, such as a colonoscopy, even when they feel perfectly healthy.
Who Should Consider a qFIT Test?
In the UK, the NHS offers bowel cancer screening using the FIT test to people aged 50 to 74 every two years. [1] However, you may also consider taking a qFIT test if you are outside this age bracket but wish to take a proactive approach to your health, or if you have a family history of bowel conditions. It is important to note that if you are experiencing active symptoms, such as unexplained weight loss, persistent changes in bowel habits, or visible bleeding, you should consult a healthcare professional immediately rather than relying solely on a screening test. [3]
Taking Control with Clinilabs
Understanding your body and taking proactive steps towards your health can provide significant peace of mind. The Quantitative Faecal Immunochemical Test (qFIT) from Clinilabs offers a convenient and reliable way to monitor your bowel health from home. This test can help provide insight into your wellbeing and may support informed conversations with a healthcare professional.
By incorporating the qFIT test into your health routine, you are making a positive choice to prioritise your long-term health. It is a simple step that can form part of a proactive approach to maintaining your wellbeing and ensuring that you are as informed as possible about your body.
Explore this topic
Continue reading the related articles in this series:
- Early detection: The Power of Early Detection: Why qFIT Matters
- Personalised insights: Personalised Insights: Understanding Your qFIT Results
- Empowerment: Peace of Mind: The Psychological Benefits of qFIT Testing
Related test: Quantitative Faecal Immunochemical Test (qFIT) at Clinilabs.
References
[1] NHS. (2024). Bowel cancer screening. https://www.nhs.uk/conditions/bowel-cancer-screening/
[2] National Institute for Health and Care Excellence (NICE). (2023). Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care. https://www.nice.org.uk/guidance/dg56
[3] Bowel Cancer UK. (2024). Symptoms of bowel cancer. https://www.bowelcanceruk.org.uk/about-bowel-cancer/symptoms/
[4] Cancer Research UK. (2024). Bowel cancer survival statistics. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer/survival